Prevention and management of gastroesophageal varices

키워드

참고문헌 (247)

1. Iwakiri Y, "The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule", Hepatology, 43(2 Suppl 1), pp.S121~S131 (2006)[DOI]
2. Garcia-Pagan JC, "Functional aspects on the pathophysiology of portal hypertension in cirrhosis", J Hepatol, 57, pp.458~461 (2012)[DOI]
3. Abraldes JG, "Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state", Am J Physiol Gastrointest Liver Physiol, 290, pp.G980~G987 (2006)[DOI]
4. Groszmann RJ, "Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis", N Engl J Med, 353, pp.2254~2261 (2005)[DOI]
5. Garcia-Tsao G, "Management of varices and variceal hemorrhage in cirrhosis", N Engl J Med, 362, pp.823~832 (2010)[DOI]
6. Graham DY, "The course of patients after variceal hemorrhage", Gastroenterology, 80, pp.800~809 (1981)
7. Gines P, "Compensated cirrhosis: natural history and prognostic factors", Hepatology, 7, pp.122~128 (1987)[DOI]
8. D’Amico G, "Competing risks and prognostic stages of cirrhosis: a 25- year inception cohort study of 494 patients", Aliment Pharmacol Ther, 39, pp.1180~1193 (2014)[DOI]
9. Kovalak M, "Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database", Gastrointest Endosc, 65, pp.82~88 (2007)[DOI]
10. Merli M, "Incidence and natural history of small esophageal varices in cirrhotic patients", J Hepatol, 38, pp.266~272 (2003)
11. North Italian Endoscopic Club for the Study, "Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study", N Engl J Med, 319, pp.983~989 (1988)[DOI]
12. McCormick PA, "Improving prognosis following a first variceal haemorrhage over four decades", Gut, 49, pp.682~685 (2001)[DOI]
13. Carbonell N, "Improved survival after variceal bleeding in patients with cirrhosis over the past two decades", Hepatology, 40, pp.652~659 (2004)[DOI]
14. Seo YS, "Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage", Hepatology, 60, pp.954~963 (2014)[DOI]
15. Villanueva C, "A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding", J Hepatol, 45, pp.560~567 (2006)[DOI]
16. Reverter E, "A MELD-based model to determine risk of mortality among patients with acute variceal bleeding", Gastroenterology, 146, pp.412~419 (2014)[DOI]
17. Bosch J, "Prevention of variceal rebleeding", Lancet, 361, pp.952~954 (2003)[DOI]
18. Moitinho E, "Prognostic value of early measurements of portal pressure in acute variceal bleeding", Gastroenterology, 117, pp.626~631 (1999)[DOI]
19. Monescillo A, "Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding", Hepatology, 40, pp.793~801 (2004)[DOI]
20. Bosch J, "The management of portal hypertension: rational basis, available treatments and future options", J Hepatol, 48(Suppl 1), pp.S68~S92 (2008)
21. de Franchis R, "Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension", J Hepatol, 63, pp.743~752 (2015)[DOI]
22. Sinagra E, "Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis", Aliment Pharmacol Ther, 39, pp.557~568 (2014)[DOI]
23. Banares R, "Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis", Hepatology, 36, pp.1367~1373 (2002)[DOI]
24. Reiberger T, "Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol", Gut, 62, pp.1634~1641 (2013)[DOI]
25. Abraldes JG, "Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats", J Hepatol, 46, pp.1040~1046 (2007)[DOI]
26. Abraldes JG, "Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial", Gastroenterology, 136, pp.1651~1658 (2009)[DOI]
27. Infante-Rivard C, "Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis", Gastroenterology, 96, pp.1087~1092 (1989)[DOI]
28. Schuman BM, "Complications of endoscopic injection sclerotherapy: a review", Am J Gastroenterol, 82, pp.823~830 (1987)
29. Tomikawa M, "Endoscopic injection sclerotherapy in the management of 2105 patients with esophageal varices", Surgery, 131(1 Suppl), pp.S171~S175 (2002)[DOI]
30. Hashizume M, "Endoscopic ligation of esophageal varices compared with injection sclerotherapy: a prospective randomized trial", Gastrointest Endosc, 39, pp.123~126 (1993)[DOI]
31. Lo GH, "A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices", Hepatology, 22, pp.466~471 (1995)[DOI]
32. Laine L, "Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleedinga meta-analysis", Ann Intern Med, 123, pp.280~287 (1995)[DOI]
33. Lo GH, "Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices", Hepatology, 25, pp.1101~1104 (1997)[DOI]
34. Stiegmann GV, "Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices", N Engl J Med, 326, pp.1527~1532 (1992)[DOI]
35. Dai C, "Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: a meta-analysis", World J Gastroenterol, 21, pp.2534~2541 (2015)[DOI]
36. Stiegmann GV, "Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices", N Engl J Med, 326, pp.1527~1532 (1992)[DOI]
37. Lo GH, "A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices", Hepatology, 22, pp.466~471 (1995)[DOI]
38. Seno H, "Improvement of collateral vessels in the vicinity of gastric cardia after endoscopic variceal ligation therapy for esophageal varices", Clin Gastroenterol Hepatol, 2, pp.400~404 (2004)[DOI]
39. Wiechowska-Kozlowska A, "Ligation of oesophageal varices may increase formation of” deep” gastric collaterals", Hepatogastroenterology, 57, pp.262~267 (2010)
40. Hwang JH, "The role of endoscopy in the management of variceal hemorrhage", Gastrointest Endosc, 80, pp.221~227 (2014)[DOI]
41. Adler DG, "ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage", Gastrointest Endosc, 60, pp.497~504 (2004)[DOI]
42. Binmoeller K, ""Superglue": the answer to variceal bleeding and fundal varices?", Endoscopy, 27, pp.392~396 (1995)[DOI]
43. Huang YH, "Endoscopic treatment of bleeding gastric varices by N-butyl- 2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety", Gastrointest Endosc, 52, pp.160~167 (2000)[DOI]
44. Lo GH, "A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices", Hepatology, 33, pp.1060~1064 (2001)[DOI]
45. Ramond MJ, "Successful endoscopic obturation of gastric varices with butyl cyanoacrylate", Hepatology, 10, pp.488~493 (1989)[DOI]
46. Soehendra N, "Endoscopic obliteration of large esophagogastric varices with bucrylate", Endoscopy, 18, pp.25~26 (1986)[DOI]
47. Wang YM, "Study of glue extrusion after endoscopic N-butyl-2-cyanoacrylate injection on gastric variceal bleeding", World J Gastroenterol, 15, pp.4945~4951 (2009)[DOI]
48. Cheng LF, "Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate", Clin Gastroenterol Hepatol, 8, pp.760~766 (2010)[DOI]
49. Ryan BM, "A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices", Gastroenterology, 126, pp.1175~1189 (2004)[DOI]
50. Bhasin DK, "Endoscopic removal of sclerotherapy needle from gastric varix after N-butyl-2-cyanoacrylate injection", Gastrointest Endosc, 51(4), pp.497~498 (2000)[DOI]
51. Lim YS, "Practical approach to endoscopic management for bleeding gastric varices", Korean J Radiol, 13, pp.S40~S44 (2012)[DOI]
52. Soehendra N, "N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy", Endoscopy, 19, pp.221~224 (1987)[DOI]
53. Zheng M, "Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update", J Clin Gastroenterol, 42, pp.507~516 (2008)[DOI]
54. LaBerge JM, "Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax", Clin Liver Dis, 10, pp.583~598 (2006)[DOI]
55. Rossle M, "The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding", N Engl J Med, 330, pp.165~171 (1994)[DOI]
56. Martin M, "Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results", Surgery, 114, pp.719~727 (1993)
57. Helton WS, "Critical appraisal of the angiographic portacaval shunt (TIPS)", The American journal of surgery, 165, pp.566~571 (1993)[DOI]
58. Chalasani N, "Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting", Gastroenterology, 118, pp.138~144 (2000)[DOI]
59. Tyburski JG, "Prognostic factors with the use of the transjugular intrahepatic portosystemic shunt for bleeding varices", Arch Surg, 132, pp.626~630 (1997)[DOI]
60. Jalan R, "Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic protosystemic stent-shunt for variceal haemorrhage", J Hepatol, 23, pp.123~128 (1995)[DOI]
61. Boyer TD, "American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension", J Vasc Interv Radiol, 16, pp.615~629 (2005)[DOI]
62. Fidelman N, "The transjugular intrahepatic portosystemic shunt: an update", AJR Am J Roentgenol, 199, pp.746~755 (2012)[DOI]
63. Madoff DC, "TIPS-related hepatic encephalopathy: management options with novel endovascular techniques", Radiographics, 24, pp.21~36 (2004)[DOI]
64. Bureau C, "Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long‐term results of a randomized multicentre study", Liver int, 27, pp.742~747 (2007)[DOI]
65. Yang Z, "Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a metaanalysis", J Gastroenterol Hepatol, 25, pp.1718~1725 (2010)[DOI]
66. Saad WE, "Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices", Semin Intervent Radiol, 28, pp.339~349 (2011)[DOI]
67. Lunderquist A, "Sclerosing injection of esophageal varices through transhepatic selective catheterization of the gastric coronary vein: A preliminary report", Acta Radiol Diagn, 15, pp.546~550 (1974)[DOI]
68. Hirota S, "Retrograde transvenous obliteration of gastric varices", Radiology, 211, pp.349~356 (1999)[DOI]
69. Kiyosue H, "Transcatheter obliteration of gas-tric varices, part 1. anatomic classification", Radiographics, 23, pp.911~920 (2003)[DOI]
70. Kiyosue H, "Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features", Radiographics, 23, pp.921~937 (2003)[DOI]
71. Koito K, "Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals", AJR Am J Roentgenol, 167, pp.1317~1320 (1996)[DOI]
72. Chikamori F, "Correlation between endoscopic and angiographic findings in patients with esophageal and isolated gastric varices", Dig Surg, 18, pp.176~181 (2001)[DOI]
73. Watanabe K, "Portal hemodynamics in patients with gastric varices: a study in 230 patients with esophageal and", or gastric varices using portal vein catheterization, 1988, pp.95, 434~440
74. Araki T, "Can balloon-occluded retrograde transvenous obliteration be performed for gastric varices without gastrorenal shunts?", J Vasc Interv Radiol, 21, pp.663~670 (2010)[DOI]
75. Matsumoto A, "Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices", Am J Gastroenterol, 94, pp.643~649 (1999)[DOI]
76. Fukuda T, "Long-term results of balloonoccluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy", J Vasc Interv Radiol, 12, pp.327~336 (2001)[DOI]
77. Ninoi T, "Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients", AJR Am J Roentgenol, 184, pp.1340~1346 (2005)[DOI]
78. Park JK, "Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis", Dig Dis Sci, 60, pp.1543~1553 (2015)[DOI]
79. Kitamoto M, "Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage", AJR Am J Roentgenol, 178, pp.1167~1174 (2002)[DOI]
80. Kanagawa H, "Treatment of gastric fundal varices by balloon‐occluded retrograde transvenous obliteration", J Gastroenterol Hepatol, 11, pp.51~58 (1996)[DOI]
81. Bellary S, "Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate", Endoscopy, 22, pp.151~ (1990)[DOI]
82. Chikamori F, "Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts", Surgery, 129, pp.414~420 (2001)[DOI]
83. Cho SK, "Balloonoccluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients", AJR Am J Roentgenol, 189, pp.365~372 (2007)[DOI]
84. Choi SY, "Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)", Eur Radiol, 21, pp.122~129 (2011)[DOI]
85. Hashizume M, "Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant", Lancet, 332, pp.340~341 (1988)[DOI]
86. Park SJ, "The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices", J Vasc Interv Radiol, 21, pp.503~507 (2010)[DOI]
87. Saad WE, "Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes", Semin Intervent Radiol, 28, pp.333~308 (2011)[DOI]
88. Sabri SS, "Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam", J Vasc Interv Radiol, 22, pp.309~316 (2011)[DOI]
89. Shimoda R, "Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts", Abdom Imaging, 30, pp.306~313 (2005)[DOI]
90. Gwon DI, "Vascular Plug-Assisted Retrograde Transvenous Obliteration for the Treatment of Gastric Varices and Hepatic Encephalopathy: A Prospective Multicenter Study", J Vasc Interv Radiol, 26, pp.1589~1595 (2015)[DOI]
91. Gwon DI, "Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration--a primary report", Radiology, 268, pp.281~287 (2013)[DOI]
92. Lee EW, "Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results", Clin Transl Gastroenterol, 5, pp.e61~ (2014)[DOI]
93. Kim YH, "Comparison of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Using Ethanolamine Oleate (EO), BRTO Using Sodium Tetradecyl Sulfate (STS) Foam and Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO)", Cardiovasc Intervent Radiol, 39, pp.840~846 (2016)[DOI]
94. Park JK, "Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy: a case report", Case Rep Radiol, 2014, pp.391420~ (2014)
95. Sarin SK, "Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension", J Clin Invest, 87, pp.1032~1036 (1991)[DOI]
96. Lin HC, "Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats", J Hepatol, 13, pp.213~219 (1991)
97. Merkel C, "A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis", Gastroenterology, 127, pp.476~484 (2004)[DOI]
98. Sarin SK, "Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial", Hepatol Int, 7, pp.248~256 (2013)[DOI]
99. Qi XS, "Nonselective betablockers in cirrhotic patients with no or small varices: A metaanalysis", World J Gastroenterol, 21, pp.3100~3108 (2015)[DOI]
100. Bhardwaj A, "Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebocontrolled trial", Gut, 66, pp.1838~1843 (2017)[DOI]
101. Villanueva C, "Development of hyperdynamic circulation and response to beta-blockers in compensated cirrhosis with portal hypertension", Hepatology, 63, pp.197~206 (2016)[DOI]
102. Bosch J, "Carvedilol: the beta-blocker of choice for portal hypertension?", Gut, 62, pp.1529~1530 (2013)[DOI]
103. Navasa M, "Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function", Gastroenterology, 96, pp.1110~1118 (1989)[DOI]
104. Angelico M, "Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis", Gastroenterology, 104, pp.1460~1465 (1993)[DOI]
105. D’Amico G, "Pharmacological treatment of portal hypertension: an evidence-based approach", Semin Liver Dis, 19, pp.475~505 (1999)[DOI]
106. Pagliaro L, "Prevention of first bleeding in cirrhosis. A metaanalysis of randomized trials of nonsurgical treatment", Ann Intern Med, 117, pp.59~70 (1992)[DOI]
107. D’Amico G, "The treatment of portal hypertension: a meta-analytic review", Hepatology, 22, pp.332~354 (1995)
108. Cheng JW, "Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients", World J Gastroenterol, 9, pp.1836~1839 (2003)[DOI]
109. Imperiale TF, "A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding", Hepatology, 33, pp.802~807 (2001)[DOI]
110. Gluud LL, "Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults", Cochrane Database Syst Rev (2012)
111. Li L, "Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis", Can J Gastroenterol, 25, pp.147~155 (2011)[DOI]
112. Gluud LL, "Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials", Am J Gastroenterol, 102, pp.2842~2848 (2007)[DOI]
113. Khuroo MS, "Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding", Aliment Pharmacol Ther, 21, pp.347~361 (2005)[DOI]
114. Hernandez-Gea V, "Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers", Am J Gastroenterol, 107, pp.418~427 (2012)[DOI]
115. Garcia-Tsao G, "Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases", Hepatology, 65, pp.310~335 (2017)[DOI]
116. Garcia-Tsao G, "Short-term effects of propranolol on portal venous pressure", Hepatology, 6, pp.101~106 (1986)[DOI]
117. Merkel C, "The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis", Hepatology, 32, pp.930~934 (2000)[DOI]
118. Sarin SK, "Long term management of oesophageal varices", Drugs, 44(Suppl 2), pp.56~69 (1992)
119. Turnes J, "Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis", Am J Gastroenterol, 101, pp.506~512 (2006)[DOI]
120. Lebrec D, "Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis", N Engl J Med, 307, pp.560~ (1982)
121. Funakoshi N, "Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding", Ann Hepatol, 11, pp.369~383 (2012)
122. Garcia-Tsao G, "Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem", Clin Gastroenterol Hepatol, 13, pp.2109~2117 (2015)[DOI]
123. Longacre AV, "A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage", Hepatology, 47, pp.169~176 (2008)
124. Sarin SK, "Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding", Am J Gastroenterol, 100, pp.797~804 (2005)[DOI]
125. Bonilha DQ, "Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial", Eur J Gastroenterol Hepatol, 27, pp.84~90 (2015)[DOI]
126. Lo GH, "Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding", Hepatology, 52, pp.230~237 (2010)[DOI]
127. Gheorghe C, "Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation", Hepatogastroenterology, 53, pp.552~557 (2006)
128. Seo YS, "Multicenter prospective randomized controlled trial comparing propranolol, endoscopic band ligation, and combination therapy for the primary prophylaxis variceal bleeding in patients with liver cirrhosis", J Hepatol, 66(Suppl 1), pp.S35~ (2017)
129. Tripathi D, "Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed", Hepatology, 50, pp.825~833 (2009)[DOI]
130. Shah HA, "Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial", J Hepatol, 60, pp.757~764 (2014)[DOI]
131. Villanueva C, "Transfusion strategies for acute upper gastrointestinal bleeding", N Engl J Med, 368, pp.11~21 (2013)[DOI]
132. Roberts I, "Is the normalisation of blood pressure in bleeding trauma patients harmful?", Lancet, 357, pp.385~387 (2001)[DOI]
133. Duggan JM, "Review article: transfusion in gastrointestinal haemorrhage--if, when and how much?", Aliment Pharmacol Ther, 15, pp.1109~1113 (2001)[DOI]
134. Blair SD, "Effect of early blood transfusion on gastrointestinal haemorrhage", Br J Surg, 73, pp.783~785 (1986)[DOI]
135. Hearnshaw SA, "Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding", Aliment Pharmacol Ther, 32, pp.215~224 (2010)[DOI]
136. Kravetz D, "Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution", Gastroenterology, 90(5), pp.1232~1240 (1986)[DOI]
137. Castaneda B, "Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats", Hepatology, 33, pp.821~825 (2001)[DOI]
138. Bendtsen F, "Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials", J Hepatol, 61, pp.252~259 (2014)[DOI]
139. Goulis J, "Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage", Hepatology, 27, pp.1207~1212 (1998)[DOI]
140. Bleichner G, "Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage", Br J Surg, 73, pp.724~726 (1986)[DOI]
141. Vivas S, "Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding", Dig Dis Sci, 46, pp.2752~2757 (2001)[DOI]
142. Bernard B, "Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study", Gastroenterology, 108, pp.1828~1834 (1995)[DOI]
143. Chavez-Tapia NC, "Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review", Aliment Pharmacol Ther, 34, pp.509~518 (2011)[DOI]
144. Tandon P, "Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child- Pugh Class, and Effects of Antibiotics", Clin Gastroenterol Hepatol, 13, pp.1189~1196 (2015)[DOI]
145. Fernandez J, "Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage", Gastroenterology, 131, pp.1049~1256 (2006)[DOI]
146. Groszmann RJ, "Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension", Hepatology, 2, pp.757~762 (1982)[DOI]
147. Ioannou G, "Terlipressin for acute esophageal variceal hemorrhage", Cochrane Database Syst Rev (2003)
148. Wells M, "Meta-analysis: vasoactive medications for the management of acute variceal bleeds", Aliment Pharmacol Ther, 35, pp.1267~1278 (2012)[DOI]
149. Bosch J, "Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin", Gastroenterology, 80, pp.518~525 (1981)
150. Azam Z, "Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial", J Hepatol, 56, pp.819~824 (2012)[DOI]
151. Sola E, "Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension", Hepatology, 52, pp.1783~1790 (2010)[DOI]
152. Yim SY, "Risk Factors for Developing Hyponatremia During Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding", J Clin Gastroenterol, 49, pp.607~612 (2015)[DOI]
153. Laine L, "Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis", Ann Intern Med, 123, pp.280~287 (1995)[DOI]
154. Banares R, "Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis", Hepatology, 35, pp.609~615 (2002)[DOI]
155. Ljubicic N, "A randomized-controlled trial of endoscopic treatment of acute esophageal variceal hemorrhage: N-butyl-2-cyanoacrylate injection vs. variceal ligation", Hepatogastroenterology, 58, pp.438~443 (2011)
156. Hsu YC, "Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage", J Gastroenterol Hepatol, 24, pp.1294~1299 (2009)[DOI]
157. Chen PH, "Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study", J Hepatol, 57, pp.1207~1213 (2012)[DOI]
158. Cheung J, "Urgent vs. nonurgent endoscopy in stable acute variceal bleeding", Am J Gastroenterol, 104, pp.1125~1129 (2009)[DOI]
159. Garcia-Pagan JC, "Early use of TIPS in patients with cirrhosis and variceal bleeding", N Engl J Med, 362, pp.2370~2379 (2010)[DOI]
160. Garcia-Pagan JC, "Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study", J Hepatol, 58, pp.45~50 (2013)[DOI]
161. Rudler M, "Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival", Aliment Pharmacol Ther, 40, pp.1074~1080 (2014)[DOI]
162. Augustin S, "Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding", Am J Gastroenterol, 106, pp.1787~1795 (2011)[DOI]
163. Conejo I, "Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding", Clin Gastroenterol Hepatol (2017)
164. Vangeli M, "Salvage tips for uncontrolled variceal bleeding", J Hepatol, 37, pp.703~704 (2002)[DOI]
165. Panes J, "Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes", Dig Dis Sci, 33, pp.454~459 (1988)[DOI]
166. Teres J, "Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube", Gastroenterology, 75, pp.566~569 (1978)
167. Haq I, "Recent advances in the management of variceal bleeding", Gastroenterol Rep (Oxf), 5, pp.113~126 (2017)[DOI]
168. Escorsell A, "Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial", Hepatology, 63, pp.1957~1967 (2016)[DOI]
169. Lebrec D, "A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report", Hepatology, 4, pp.355~358 (1984)[DOI]
170. Garden OJ, "Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial", Gastroenterology, 98, pp.185~190 (1990)[DOI]
171. Colombo M, "Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial", Hepatology, 9, pp.433~438 (1989)[DOI]
172. Garcia-Pagan JC, "Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study", Ann Intern Med, 114, pp.869~873 (1991)[DOI]
173. Gournay J, "Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding", Hepatology, 31, pp.1239~1245 (2000)[DOI]
174. Gluud LL, "Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices", Aliment Pharmacol Ther, 32, pp.859~871 (2010)[DOI]
175. Villanueva C, "Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding", N Engl J Med, 334, pp.1624~1629 (1996)[DOI]
176. Cheung J, "Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices", Aliment Pharmacol Ther, 30, pp.577~588 (2009)[DOI]
177. Ding SH, "Efficacy of beta-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: a meta-analysis", World J Gastroenterol, 15, pp.2151~2155 (2009)[DOI]
178. Lo GH, "Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding", Hepatology, 48, pp.580~587 (2008)[DOI]
179. Kumar A, "Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence", Gastroenterology, 137, pp.892~901 (2009)[DOI]
180. Garcia-Pagan JC, "Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial", Gut, 58, pp.1144~1150 (2009)[DOI]
181. Lo GH, "A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding", J Gastroenterol Hepatol, 24, pp.982~987 (2009)[DOI]
182. de Franchis R, "Endoscopic treatments for portal hypertension", Semin Liver Dis, 19, pp.439~455 (1999)[DOI]
183. Singh P, "Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis", Am J Gastroenterol, 97, pp.623~629 (2002)[DOI]
184. Karsan HA, "Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis", Dig Dis Sci, 50, pp.399~406 (2005)[DOI]
185. Lo GH, "Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial", Hepatology, 32, pp.461~465 (2000)[DOI]
186. de la Pena J, "Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial", Hepatology, 41, pp.572~578 (2005)[DOI]
187. Gonzalez R, "Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis", Ann Intern Med, 149, pp.109~122 (2008)[DOI]
188. Puente A, "Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review", Liver Int, 34, pp.823~833 (2014)[DOI]
189. Stanley AJ, "Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding", J Hepatol, 61, pp.1014~1019 (2014)[DOI]
190. Lo GH, "Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding", J Gastroenterol Hepatol, 27, pp.1681~1687 (2012)[DOI]
191. Leithead JA, "Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation", Gut, 64, pp.1111~1119 (2015)[DOI]
192. Abraldes JG, "Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis", Gastroenterology, 150, pp.1160~1170 (2016)[DOI]
193. Sauerbruch T, "Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy", Gastroenterology, 149, pp.660~668 (2015)[DOI]
194. Sarin SK, "Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)[DOI]
195. Kim T, "Risk factors for hemorrhage from gastric fundal varices", Hepatology, 25, pp.307~312 (1997)[DOI]
196. Korula J, "Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy", Dig Dis Sci, 36, pp.303~309 (1991)[DOI]
197. Mitchell KJ, "A prospective reappraisal of emergency endoscopy in patients with portal hypertension", Scand J Gastroenterol, 17, pp.965~968 (1982)
198. de Franchis R, "Natural history of portal hypertension in patients with cirrhosis", Clin Liver Dis, 5, pp.645~663 (2001)[DOI]
199. Trudeau W, "Endoscopic injection sclerosis in bleeding gastric varices", Gastrointest Endosc, 32, pp.264~268 (1986)[DOI]
200. Ryan BM, "A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices", Gastroenterology, 126, pp.1175~1189 (2004)[DOI]
201. Tan PC, "A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation", Hepatology, 43, pp.690~697 (2006)[DOI]
202. 김문영, "Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data", Clinical and Molecular Hepatology, 19(1), pp.36~44 (2013), 대한간학회[DOI]
203. Arakawa M, "Pathomorphology of esophageal and gastric varices", Semin Liver Dis, 22, pp.73~82 (2002)[DOI]
204. Toubia N, "Portal hypertension and variceal hemorrhage", Med Clin North Am, 92, pp.551~574 (2008)[DOI]
205. Takeuchi M, "Endoscopic ligation of gastric varices", Lancet, 348, pp.1038~ (1996)
206. Vitte RL, "Fatal outcome following endoscopic fundal variceal ligation", Gastrointest Endosc, 43, pp.82~ (1996)
207. Garcia-Pagan JC, "Management of gastric varices", Clin Gastroenterol Hepatol, 12, pp.919~928 (2014)[DOI]
208. Qureshi W, "ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005", Gastrointest Endosc, 62, pp.651~655 (2005)[DOI]
209. Lo GH, "A retrospective comparative study of histoacryl injection and banding ligation in the treatment of acute type 1 gastric variceal hemorrhage", Scand J Gastroenterol, 48, pp.1198~1204 (2013)[DOI]
210. Matsumoto A, "Balloon endoscopic sclerotherapy, a novel treatment for high-risk gastric fundal varices: a pilot study", Gastroenterology, 117, pp.515~516 (1999)[DOI]
211. Watanabe K, "Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and", or gastric varices using portal vein catheterization, 1988, pp.95, 434~440
212. Mishra SR, "Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial", J Hepatol, 54, pp.1161~1167 (2011)[DOI]
213. Fukuda T, "Long-term results of balloonoccluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy", J Vasc Interv Radiol, 12, pp.327~336 (2001)[DOI]
214. Vianna A, "Normal venous circulation of the gastroesophageal junction. A route to understanding varices", Gastroenterology, 93, pp.876~889 (1987)[DOI]
215. Kitano S, "Venous anatomy of the lower oesophagus in portal hypertension: practical implications", Br J Surg, 73, pp.525~531 (1986)[DOI]
216. Grobe JL, "Venography during endoscopic injection sclerotherapy of esophageal varices", Gastrointest Endosc, 30, pp.6~8 (1984)[DOI]
217. Park SW, "Changes in Cardiac Varices and Their Clinical Significance after Eradication of Esophageal Varices by Band Ligation", Can J Gastroenterol Hepatol, 2016, pp.2198163~ (2016)
218. Sarin SK, "A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices", Am J Gastroenterol, 97, pp.1010~1015 (2002)[DOI]
219. Hou MC, "A randomized trial of endoscopic cyanoacrylate injection for acute gastric variceal bleeding:0.5 mL versus 1.0 mL", Gastrointest Endosc, 70, pp.668~675 (2009)[DOI]
220. Kind R, "Bucrylate treatment of bleeding gastric varices: 12 years' experience", Endoscopy, 32, pp.512~519 (2000)[DOI]
221. Akahoshi T, "Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience", J Gastroenterol Hepatol, 23, pp.1702~1709 (2008)[DOI]
222. Akahoshi T, "Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience", Surgery, 131(1 Suppl), pp.S176~S181 (2002)[DOI]
223. Tantau M, "Band ligation vs. NButyl- 2-cyanoacrylate injection in acute gastric variceal bleeding: a prospective follow-up study", Ann Hepatol, 13, pp.75~83 (2013)
224. Qiao W, "Cyanoacrylate Injection Versus Band Ligation in the Endoscopic Management of Acute Gastric Variceal Bleeding: Meta-Analysis of Randomized, Controlled Studies Based on the PRISMA Statement", Medicine (Baltimore), 94, pp.e1725~ (2015)[DOI]
225. Sarin SK, "Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience", Gastrointest Endosc, 46, pp.8~14 (1997)[DOI]
226. Ogawa K, "Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding", J Gastroenterol Hepatol, 14, pp.245~250 (1999)
227. Chau TN, ""Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding", Gastroenterology, 114, pp.981~987 (1998)[DOI]
228. Barange K, "Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices", Hepatology, 30, pp.1139~1143 (1999)[DOI]
229. 최영호, "Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleeding:Its Feasibility Compared with Transjugular Intrahepatic Portosystemic Shunt", Korean Journal of Radiology, 4(2), pp.6~116 (2003), 대한영상의학회
230. 조성기, "The Short-Term Effects of Balloon-Occluded Retrograde Transvenous Obliteration, for Treating Gastric Variceal Bleeding, on Portal Hypertensive Changes: a CT Evaluation", Korean Journal of Radiology, 8(6), pp.520~530 (2007), 대한영상의학회
231. Lo GH, "A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices", Hepatology, 33, pp.1060~1064 (2001)[DOI]
232. 박상정, "Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach", Clinical and Molecular Hepatology, 22(4), pp.487~494 (2016), 대한간학회[DOI]
233. 주현수, "위정맥류 치료에서 Histoacryl？ (N-butyl-2-cyanoacrylate) 주입술의 장기성적 보고 -10년 경험", 대한소화기학회지, 49(5), pp.320~326 (2007), 대한소화기학회
234. Rajoriya N, "Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding", QJM, 104, pp.41~47 (2011)[DOI]
235. Choudhuri G, "Long-term efficacy and safety of N-butylcyanoacrylate in endoscopic treatment of gastric varices", Trop Gastroenterol, 31, pp.155~164 (2010)
236. Belletrutti PJ, "Endoscopic management of gastric varices: efficacy and outcomes of gluing with N-butyl-2-cyanoacrylate in a North American patient population", Can J Gastroenterol, 22, pp.931~936 (2008)[DOI]
237. Marques P, "Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate", Dig Dis Sci, 53, pp.544~550 (2008)[DOI]
238. Fry LC, "Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices", Dig Dis, 26, pp.300~303 (2008)[DOI]
239. Cheng LF, "Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 years' experience of 635 cases", Chin Med J (Engl), 120, pp.2081~2085 (2007)
240. Goh HG, "Treatment efficacy of endoscopic variceal obturation for gastric variceal bleeding according to the type of varices", Clin Mol Hepatol, 23(Suppl 2), pp.S103~ (2017)[DOI]
241. Evrard S, "Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial", Endoscopy, 35, pp.729~735 (2003)[DOI]
242. Mishra SR, "Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial", Gut, 59, pp.729~735 (2010)[DOI]
243. Hung HH, "Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial", J Hepatol, 56, pp.1025~1032 (2012)
244. Lo GH, "A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding", Endoscopy, 39, pp.679~685 (2007)[DOI]
245. Patel A, "Balloon-occluded retrograde transvenous obliteration of gastric varices", AJR Am J Roentgenol, 199, pp.721~729 (2012)[DOI]
246. Ninoi T, "Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients", AJR Am J Roentgenol, 184, pp.1340~1346 (2005)[DOI]
247. 홍형주, "Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding", 전남의대학술지, 49(1), pp.14~19 (2013), 의과학연구소

관련 논문AI추천